MetLife Investment Management’s OptimizeRx OPRX Stock Holding History

MetLife Investment Management’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-9,844	Closed	-$121K	–	2823
2025 Q4	$121K	Sell	9,844 -1,535	-13%	-$25.1K	﹤0.01%	2521
2025 Q3	$233K	Hold	11,379	–	–	﹤0.01%	2229
2025 Q2	$154K	Hold	11,379	–	–	﹤0.01%	2323
2025 Q1	$98.5K	Buy	+11,379	New	+$69.6K	﹤0.01%	2534
2024 Q4	–	Sell	-10,083	Closed	-$77.8K	–	2842
2024 Q3	$77.8K	Hold	10,083	–	–	﹤0.01%	2700
2024 Q2	$101K	Buy	10,083 +925	+10%	+$10.2K	﹤0.01%	2600
2024 Q1	$111K	Hold	9,158	–	–	﹤0.01%	2482
2023 Q4	$131K	Hold	9,158	–	–	﹤0.01%	2471
2023 Q3	$71.2K	Hold	9,158	–	–	﹤0.01%	2754
2023 Q2	$131K	Hold	9,158	–	–	﹤0.01%	2528
2023 Q1	$134K	Hold	9,158	–	–	﹤0.01%	2433
2022 Q4	$154K	Hold	9,158	–	–	﹤0.01%	2402
2022 Q3	$136K	Hold	9,158	–	–	﹤0.01%	2524
2022 Q2	$251K	Hold	9,158	–	–	﹤0.01%	2153
2022 Q1	$345K	Buy	9,158 +3,371	+58%	+$149K	﹤0.01%	2008
2021 Q4	$359K	Hold	5,787	–	–	﹤0.01%	1689
2021 Q3	$495K	Hold	5,787	–	–	﹤0.01%	1530
2021 Q2	$358K	Hold	5,787	–	–	﹤0.01%	1778
2021 Q1	$282K	Sell	5,787 -2,003	-26%	-$96.6K	﹤0.01%	1852
2020 Q4	$243K	Hold	7,790	–	–	﹤0.01%	1869
2020 Q3	$162K	Buy	+7,790	New	+$134K	﹤0.01%	1988

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MetLife Investment Management's OPRX Position: Q1 2026 in Review

MetLife Investment Management sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 9,844 shares — an estimated $121K sold.

MetLife Investment Management first reported a position in OPRX in Q3 2020 and held it in 21 quarters. The position peaked at $495K in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

MetLife Investment Management reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
MetLife Investment Management sold 9,844 OptimizeRx shares in Q1 2026, an estimated $121K.
MetLife Investment Management first reported a position in OptimizeRx in Q3 2020 and held it in 21 quarters.
MetLife Investment Management's OptimizeRx position peaked at $495K in Q3 2021.
128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.